UPDATE 2-Pfizer, Allergan scrap $160 bln deal after U.S. tax rule change

April 6 (Reuters) - U.S. drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes.